LENSAR’s Ally Laser Cataract System cleared by FDA: Parkhurst NuVision will be among the first in US to offer
June 14, 2022 11:00 ET
|
Parkhurst NuVision
San Antonio, June 14, 2022 (GLOBE NEWSWIRE) -- The Ally Lensar laser is a cataract treatment system that combines a femtosecond laser for cataract surgery with phacoemulsification in a single...
EVO ICL UNITED STATES LAUNCH: First group of patients race to Parkhurst Nuvision in San Antonio for new LASIK Eye Surgery Alternative
April 06, 2022 00:43 ET
|
Parkhurst NuVision
San Antonio, Texas , April 05, 2022 (GLOBE NEWSWIRE) -- With the recent FDA approval of EVO Visian® ICL (referred to as “EVO”), patients are lining up to get the new vision procedure now available...
EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE UNITED STATES TO OFFER THIS EVOLUTIONARY VISION CORRECTION PROCEDURE
March 28, 2022 11:25 ET
|
Parkhurst NuVision
San Antonio, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL (referred to as “EVO”) is an evolutionary innovation in vision correction surgery. EVO ICL is an implantable lens placed just...